PATENT CLAIM ANALYSIS

Application Number: 15892078
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "561000"]

Abstract:
Compositions contain citrulline and leucine or a metabolite thereof including, for example, a synergistic amount of citrulline and leucine. Such compositions may be used in methods for the treatment of pre-diabetes, metabolic syndrome, hyperglycemia, or diabetes.

Claim (Index 10):
The method of  claim 1 , wherein a pharmaceutical composition is administered to the subject that comprises both the therapeutically effective amount of the citrulline and the therapeutically effective amount of the leucine or metabolite thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15027580', '15891324', '14248787', '14851668', '15226267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7289240453332672
- 35 USC 102 Novelty (BERT): 0.5534977454634081
- Combined Prediction Score: 0.7113814153462813
- Mean Citation Score: 259.033282
- Max Citation Score: 406.64493
- Similarity Product: 376.74541155014987

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test